Novo Nordisk(NVO) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ _________________________ _________________________ FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 February 2, 2022 NOVO NORDISK A/S (Exact name of Registrant as specified in its charter) | --- | |---------------------------| | | | | | | | | | _________________________ | | | | | | | | | | | | | | | | | | | (Adress of principal executive offices ...